U.S. flag

An official website of the United States government

Format
Items per page
Sort by
Choose Destination

Links from MedGen

Items: 1 to 100 of 2528

VariationLocationGene(s)Protein changeCondition(s)Clinical significance
(Last reviewed)
Review status
1.
GRCh37:
Chr2:71894601
GRCh38:
Chr2:71667471
DYSFE1752K, E1753K, E1766K, E1767K, E1773K, E1774K, E1783K, E1784K, E1787K, E1788K, E1797K, E1798K, E1804K, E1805Knot provided, Qualitative or quantitative defects of dysferlinConflicting interpretations of pathogenicity
(Mar 13, 2023)
criteria provided, conflicting interpretations
2.
GRCh37:
Chr2:71900503-71913622
DYSFQualitative or quantitative defects of dysferlinPathogenic
(Jun 14, 2022)
criteria provided, single submitter
3.
GRCh37:
Chr2:71707993-71709120
DYSFQualitative or quantitative defects of dysferlinPathogenic
(Jul 27, 2022)
criteria provided, single submitter
4.
GRCh37:
Chr2:71793585-71797846
DYSFQualitative or quantitative defects of dysferlinPathogenic
(Jan 28, 2019)
criteria provided, single submitter
5.
GRCh37:
Chr2:71693963-71744179
DYSFQualitative or quantitative defects of dysferlinLikely pathogenic
(Apr 28, 2022)
criteria provided, single submitter
6.
GRCh37:
Chr2:71755408-71755551
DYSFQualitative or quantitative defects of dysferlinLikely pathogenic
(Apr 28, 2022)
criteria provided, single submitter
7.
GRCh37:
Chr2:71681129-71913622
DYSFQualitative or quantitative defects of dysferlinUncertain significance
(Apr 15, 2021)
criteria provided, single submitter
8.
GRCh37:
Chr2:71838365-71840553
DYSFQualitative or quantitative defects of dysferlinPathogenic
(Feb 6, 2022)
criteria provided, single submitter
9.
GRCh37:
Chr2:71730324-71730469
DYSFQualitative or quantitative defects of dysferlinPathogenic
(Feb 11, 2022)
criteria provided, single submitter
10.
GRCh37:
Chr2:71827822-71827982
DYSFQualitative or quantitative defects of dysferlinPathogenic
(Mar 26, 2022)
criteria provided, single submitter
11.
GRCh37:
Chr2:71801318-71801511
DYSFQualitative or quantitative defects of dysferlinPathogenic
(Sep 18, 2022)
criteria provided, single submitter
12.
GRCh37:
Chr2:71681119-71694073
DYSFQualitative or quantitative defects of dysferlinPathogenic
(Oct 3, 2022)
criteria provided, single submitter
13.
GRCh37:
Chr2:71740885
GRCh38:
Chr2:71513755
DYSFT166S, T167S, T197S, T198SQualitative or quantitative defects of dysferlinLikely benign
(Apr 29, 2022)
criteria provided, single submitter
14.
GRCh37:
Chr2:71796983
GRCh38:
Chr2:71569853
DYSFQualitative or quantitative defects of dysferlinLikely benign
(Oct 23, 2022)
criteria provided, single submitter
15.
GRCh37:
Chr2:71743392
GRCh38:
Chr2:71516262
DYSFQualitative or quantitative defects of dysferlinLikely benign
(Jun 4, 2022)
criteria provided, single submitter
16.
GRCh37:
Chr2:71747987
GRCh38:
Chr2:71520857
DYSFY336H, Y337H, Y367H, Y368HQualitative or quantitative defects of dysferlinUncertain significance
(Oct 10, 2022)
criteria provided, single submitter
17.
GRCh37:
Chr2:71740983
GRCh38:
Chr2:71513853
DYSFG199R, G200R, G230R, G231RQualitative or quantitative defects of dysferlinLikely benign
(Oct 13, 2022)
criteria provided, single submitter
18.
GRCh37:
Chr2:71839931-71839932
GRCh38:
Chr2:71612801-71612802
DYSFG1429V, G1430V, G1443V, G1444V, G1460V, G1461V, G1474V, G1475VQualitative or quantitative defects of dysferlinUncertain significance
(Jan 2, 2022)
criteria provided, single submitter
19.
GRCh37:
Chr2:71838738
GRCh38:
Chr2:71611608
DYSFQualitative or quantitative defects of dysferlinLikely benign
(Jan 2, 2022)
criteria provided, single submitter
20.
GRCh37:
Chr2:71825761
GRCh38:
Chr2:71598631
DYSFQualitative or quantitative defects of dysferlinLikely benign
(May 12, 2022)
criteria provided, single submitter
21.
GRCh37:
Chr2:71886163
GRCh38:
Chr2:71659033
DYSFK1584N, K1585N, K1598N, K1599N, K1605N, K1606N, K1615N, K1616N, K1619N, K1620N, K1629N, K1630N, K1636N, K1637NQualitative or quantitative defects of dysferlinUncertain significance
(Aug 5, 2022)
criteria provided, single submitter
22.
GRCh37:
Chr2:71739014
GRCh38:
Chr2:71511884
DYSFQualitative or quantitative defects of dysferlinLikely benign
(Apr 5, 2022)
criteria provided, single submitter
23.
GRCh37:
Chr2:71778859
GRCh38:
Chr2:71551729
DYSFQualitative or quantitative defects of dysferlinLikely benign
(Apr 21, 2022)
criteria provided, single submitter
24.
GRCh37:
Chr2:71886136
GRCh38:
Chr2:71659006
DYSFQualitative or quantitative defects of dysferlinLikely benign
(Apr 12, 2022)
criteria provided, single submitter
25.
GRCh37:
Chr2:71839833
GRCh38:
Chr2:71612703
DYSFQualitative or quantitative defects of dysferlinLikely benign
(Feb 13, 2022)
criteria provided, single submitter
26.
GRCh37:
Chr2:71778244
GRCh38:
Chr2:71551114
DYSFQualitative or quantitative defects of dysferlinLikely benign
(Mar 9, 2022)
criteria provided, single submitter
27.
GRCh37:
Chr2:71817405
GRCh38:
Chr2:71590275
DYSFQualitative or quantitative defects of dysferlinLikely benign
(Mar 5, 2022)
criteria provided, single submitter
28.
GRCh37:
Chr2:71825693
GRCh38:
Chr2:71598563
DYSFQualitative or quantitative defects of dysferlinPathogenic
(May 7, 2022)
criteria provided, single submitter
29.
GRCh37:
Chr2:71780930
GRCh38:
Chr2:71553800
DYSFQualitative or quantitative defects of dysferlinLikely benign
(May 5, 2022)
criteria provided, single submitter
30.
GRCh37:
Chr2:71839760
GRCh38:
Chr2:71612630
DYSFQualitative or quantitative defects of dysferlinLikely benign
(Aug 13, 2022)
criteria provided, single submitter
31.
GRCh37:
Chr2:71797072
GRCh38:
Chr2:71569942
DYSFQualitative or quantitative defects of dysferlinLikely benign
(Apr 6, 2022)
criteria provided, single submitter
32.
GRCh37:
Chr2:71839926
GRCh38:
Chr2:71612796
DYSFQ1442H, Q1428H, Q1459H, Q1472H, Q1441H, Q1458H, Q1427H, Q1473HQualitative or quantitative defects of dysferlinUncertain significance
(Dec 24, 2021)
criteria provided, single submitter
33.
GRCh37:
Chr2:71906223-71906231
GRCh38:
Chr2:71679093-71679101
DYSFQualitative or quantitative defects of dysferlinUncertain significance
(Mar 10, 2022)
criteria provided, single submitter
34.
GRCh37:
Chr2:71838613
GRCh38:
Chr2:71611483
DYSFR1329G, R1373G, R1374G, R1342G, R1343G, R1359G, R1328G, R1360GQualitative or quantitative defects of dysferlinPathogenic
(Jul 13, 2022)
criteria provided, single submitter
35.
GRCh37:
Chr2:71783115
GRCh38:
Chr2:71555985
DYSFH694fs, H710fs, H679fs, H693fs, H711fs, H680fs, H724fs, H725fsQualitative or quantitative defects of dysferlinPathogenic
(Jul 12, 2022)
criteria provided, single submitter
36.
GRCh37:
Chr2:71753461
GRCh38:
Chr2:71526331
DYSFE390*, E420*, E389*, E421*Qualitative or quantitative defects of dysferlinPathogenic
(Jun 11, 2022)
criteria provided, single submitter
37.
GRCh37:
Chr2:71740868-71740869
GRCh38:
Chr2:71513738-71513739
DYSFE161fs, E192fs, E193fs, E162fsQualitative or quantitative defects of dysferlinPathogenic
(May 23, 2022)
criteria provided, single submitter
38.
GRCh37:
Chr2:71738950
GRCh38:
Chr2:71511820
DYSFL120P, L119PQualitative or quantitative defects of dysferlinPathogenic
(Feb 15, 2022)
criteria provided, single submitter
39.
GRCh37:
Chr2:71730450
GRCh38:
Chr2:71503320
DYSFQualitative or quantitative defects of dysferlinPathogenic
(Sep 24, 2022)
criteria provided, single submitter
40.
GRCh37:
Chr2:71894659
GRCh38:
Chr2:71667529
DYSFQualitative or quantitative defects of dysferlinLikely benign
(Sep 20, 2022)
criteria provided, single submitter
41.
GRCh37:
Chr2:71791213
GRCh38:
Chr2:71564083
DYSFV780D, V812D, V825D, V781D, V811D, V826D, V794D, V795DQualitative or quantitative defects of dysferlin, not providedUncertain significance
(Aug 25, 2021)
criteria provided, multiple submitters, no conflicts
42.
GRCh37:
Chr2:71871138
GRCh38:
Chr2:71644008
DYSFI1486T, I1507T, I1523T, I1524T, I1471T, I1472T, I1492T, I1493T, I1516T, I1517T, I1502T, I1506T, I1485T, I1503TQualitative or quantitative defects of dysferlinLikely benign
(Oct 30, 2022)
criteria provided, single submitter
43.
GRCh37:
Chr2:71906228
GRCh38:
Chr2:71679098
DYSFK1923E, K1944E, K1954E, K1959E, K1938E, K1955E, K1958E, K1968E, K1976E, K1945E, K1975E, K1924E, K1937E, K1969EQualitative or quantitative defects of dysferlinUncertain significance
(Dec 25, 2021)
criteria provided, single submitter
44.
GRCh37:
Chr2:71838456
GRCh38:
Chr2:71611326
DYSFL1330F, L1347F, L1315F, L1316F, L1329F, L1360F, L1346F, L1361FQualitative or quantitative defects of dysferlinBenign
(Jun 26, 2022)
criteria provided, single submitter
45.
GRCh37:
Chr2:71908172
GRCh38:
Chr2:71681042
DYSFQualitative or quantitative defects of dysferlinLikely benign
(Oct 13, 2022)
criteria provided, single submitter
46.
GRCh37:
Chr2:71906211
GRCh38:
Chr2:71679081
DYSFR1931H, R1939H, R1953H, R1970H, R1952H, R1969H, R1917H, R1938H, R1949H, R1918H, R1932H, R1948H, R1962H, R1963HQualitative or quantitative defects of dysferlinLikely benign
(May 25, 2022)
criteria provided, single submitter
47.
GRCh37:
Chr2:71829912
GRCh38:
Chr2:71602782
DYSF, LOC122787137E1294K, E1295K, E1311K, E1325K, E1312K, E1326K, E1280K, E1281KQualitative or quantitative defects of dysferlinUncertain significance
(Jun 1, 2022)
criteria provided, single submitter
48.
GRCh37:
Chr2:71681153
GRCh38:
Chr2:71454023
DYSFA9TQualitative or quantitative defects of dysferlinUncertain significance
(May 12, 2022)
criteria provided, single submitter
49.
GRCh37:
Chr2:71796930
GRCh38:
Chr2:71569800
DYSFQualitative or quantitative defects of dysferlinUncertain significance
(Mar 29, 2022)
criteria provided, single submitter
50.
GRCh37:
Chr2:71797711
GRCh38:
Chr2:71570581
DYSFQualitative or quantitative defects of dysferlinLikely benign
(Jul 19, 2022)
criteria provided, single submitter
51.
GRCh37:
Chr2:71801515
GRCh38:
Chr2:71574385
DYSFQualitative or quantitative defects of dysferlinLikely benign
(Apr 21, 2022)
criteria provided, single submitter
52.
GRCh37:
Chr2:71776531
GRCh38:
Chr2:71549401
DYSFQualitative or quantitative defects of dysferlinLikely benign
(May 29, 2022)
criteria provided, single submitter
53.
GRCh37:
Chr2:71829950
GRCh38:
Chr2:71602820
LOC122787137, DYSFQualitative or quantitative defects of dysferlinLikely benign
(Jul 27, 2022)
criteria provided, single submitter
54.
GRCh37:
Chr2:71896743
GRCh38:
Chr2:71669613
DYSFI1845T, I1846T, I1853T, I1862T, I1852T, I1876T, I1884T, I1831T, I1832T, I1863T, I1866T, I1867T, I1877T, I1883TInborn genetic diseases, Qualitative or quantitative defects of dysferlinUncertain significance
(Dec 21, 2021)
criteria provided, multiple submitters, no conflicts
55.
GRCh37:
Chr2:71896890
GRCh38:
Chr2:71669760
DYSFQualitative or quantitative defects of dysferlinLikely benign
(Mar 19, 2022)
criteria provided, single submitter
56.
GRCh37:
Chr2:71909699
GRCh38:
Chr2:71682569
DYSFQualitative or quantitative defects of dysferlinLikely benign
(Sep 15, 2022)
criteria provided, single submitter
57.
GRCh37:
Chr2:71871088
GRCh38:
Chr2:71643958
DYSFQualitative or quantitative defects of dysferlinLikely benign
(Jun 10, 2022)
criteria provided, single submitter
58.
GRCh37:
Chr2:71740853
GRCh38:
Chr2:71513723
DYSFQualitative or quantitative defects of dysferlinLikely benign
(Oct 28, 2022)
criteria provided, single submitter
59.
GRCh37:
Chr2:71896267
GRCh38:
Chr2:71669137
DYSFN1806Y, N1820Y, N1836Y, N1851Y, N1857Y, N1805Y, N1826Y, N1858Y, N1819Y, N1840Y, N1850Y, N1827Y, N1837Y, N1841YQualitative or quantitative defects of dysferlinUncertain significance
(Sep 15, 2020)
criteria provided, single submitter
60.
GRCh37:
Chr2:71840477
GRCh38:
Chr2:71613347
DYSFQualitative or quantitative defects of dysferlinLikely benign
(Oct 29, 2022)
criteria provided, single submitter
61.
GRCh37:
Chr2:71825708
GRCh38:
Chr2:71598578
DYSFV1180I, V1197I, V1196I, V1165I, V1166I, V1179I, V1211I, V1210IQualitative or quantitative defects of dysferlin, not providedUncertain significance
(Jul 12, 2022)
criteria provided, multiple submitters, no conflicts
62.
GRCh37:
Chr2:71753404
GRCh38:
Chr2:71526274
DYSFR370W, R402W, R371W, R401WQualitative or quantitative defects of dysferlinUncertain significance
(Apr 29, 2022)
criteria provided, single submitter
63.
GRCh37:
Chr2:71838720
GRCh38:
Chr2:71611590
DYSFQualitative or quantitative defects of dysferlinLikely benign
(Jul 21, 2022)
criteria provided, single submitter
64.
GRCh37:
Chr2:71797756-71797757
GRCh38:
Chr2:71570626-71570627
DYSFE1007fs, E1008fs, E1038fs, E1039fs, E1052fs, E1022fs, E1021fs, E1053fsQualitative or quantitative defects of dysferlinPathogenic
(Jun 4, 2022)
criteria provided, single submitter
65.
GRCh37:
Chr2:71783212
GRCh38:
Chr2:71556082
DYSFQualitative or quantitative defects of dysferlinLikely benign
(Oct 26, 2022)
criteria provided, single submitter
66.
GRCh37:
Chr2:71838442
GRCh38:
Chr2:71611312
DYSFN1311T, N1324T, N1356T, N1310T, N1325T, N1342T, N1355T, N1341TQualitative or quantitative defects of dysferlinUncertain significance
(Feb 20, 2022)
criteria provided, single submitter
67.
GRCh37:
Chr2:71780951
GRCh38:
Chr2:71553821
DYSFY635H, Y636H, Y649H, Y667H, Y681H, Y650H, Y666H, Y680HQualitative or quantitative defects of dysferlinLikely benign
(Oct 19, 2022)
criteria provided, single submitter
68.
GRCh37:
Chr2:71744177
GRCh38:
Chr2:71517047
DYSFQualitative or quantitative defects of dysferlinLikely benign
(Jan 5, 2022)
criteria provided, single submitter
69.
GRCh37:
Chr2:71838488
GRCh38:
Chr2:71611358
DYSFQualitative or quantitative defects of dysferlinLikely benign
(Aug 1, 2022)
criteria provided, single submitter
70.
GRCh37:
Chr2:71762384
GRCh38:
Chr2:71535254
DYSFQualitative or quantitative defects of dysferlinLikely benign
(May 6, 2022)
criteria provided, single submitter
71.
GRCh37:
Chr2:71755530
GRCh38:
Chr2:71528400
DYSFM429T, M459T, M460T, M428TQualitative or quantitative defects of dysferlinUncertain significance
(Apr 23, 2022)
criteria provided, single submitter
72.
GRCh37:
Chr2:71766337
GRCh38:
Chr2:71539207
DYSFS483W, S484W, S515W, S514WQualitative or quantitative defects of dysferlinUncertain significance
(Aug 27, 2021)
criteria provided, single submitter
73.
GRCh37:
Chr2:71780166
GRCh38:
Chr2:71553036
DYSFS610F, S611F, S580F, S594F, S625F, S593F, S624F, S579FQualitative or quantitative defects of dysferlinUncertain significance
(Oct 17, 2022)
criteria provided, single submitter
74.
GRCh37:
Chr2:71796936-71796937
GRCh38:
Chr2:71569806-71569807
DYSFQualitative or quantitative defects of dysferlinLikely benign
(May 15, 2022)
criteria provided, single submitter
75.
GRCh37:
Chr2:71744183
GRCh38:
Chr2:71517053
DYSFQualitative or quantitative defects of dysferlinLikely benign
(Oct 27, 2022)
criteria provided, single submitter
76.
GRCh37:
Chr2:71883301
GRCh38:
Chr2:71656171
DYSFT1514A, T1539A, T1507A, T1524A, T1538A, T1545A, T1508A, T1546A, T1493A, T1494A, T1515A, T1525A, T1528A, T1529AQualitative or quantitative defects of dysferlinUncertain significance
(Sep 15, 2022)
criteria provided, single submitter
77.
GRCh37:
Chr2:71817336
GRCh38:
Chr2:71590206
DYSFQualitative or quantitative defects of dysferlinLikely benign
(Aug 5, 2022)
criteria provided, single submitter
78.
GRCh37:
Chr2:71778775
GRCh38:
Chr2:71551645
DYSFQualitative or quantitative defects of dysferlinLikely benign
(Jun 19, 2022)
criteria provided, single submitter
79.
GRCh37:
Chr2:71747996
GRCh38:
Chr2:71520866
DYSFT340A, T370A, T339A, T371AQualitative or quantitative defects of dysferlinUncertain significance
(Jan 21, 2022)
criteria provided, single submitter
80.
GRCh37:
Chr2:71913570
GRCh38:
Chr2:71686440
DYSFQualitative or quantitative defects of dysferlinLikely benign
(May 4, 2022)
criteria provided, single submitter
81.
GRCh37:
Chr2:71797482
GRCh38:
Chr2:71570352
DYSFQualitative or quantitative defects of dysferlinLikely benign
(Jun 25, 2022)
criteria provided, single submitter
82.
GRCh37:
Chr2:71896725
GRCh38:
Chr2:71669595
DYSFQualitative or quantitative defects of dysferlinLikely benign
(Sep 26, 2022)
criteria provided, single submitter
83.
GRCh37:
Chr2:71708989
GRCh38:
Chr2:71481859
DYSFQualitative or quantitative defects of dysferlinLikely benign
(Sep 13, 2022)
criteria provided, single submitter
84.
GRCh37:
Chr2:71801357
GRCh38:
Chr2:71574227
DYSFQualitative or quantitative defects of dysferlinLikely benign
(Apr 4, 2022)
criteria provided, single submitter
85.
GRCh37:
Chr2:71797751
GRCh38:
Chr2:71570621
DYSFI1005M, I1004M, I1019M, I1035M, I1050M, I1018M, I1049M, I1036MQualitative or quantitative defects of dysferlinUncertain significance
(Mar 20, 2022)
criteria provided, single submitter
86.
GRCh37:
Chr2:71740879
GRCh38:
Chr2:71513749
DYSFG165E, G195E, G196E, G164EQualitative or quantitative defects of dysferlinUncertain significance
(Oct 19, 2020)
criteria provided, single submitter
87.
GRCh37:
Chr2:71871186
GRCh38:
Chr2:71644056
DYSFT1502I, T1539I, T1508I, T1519I, T1523I, T1533I, T1540I, T1488I, T1501I, T1509I, T1522I, T1532I, T1487I, T1518IQualitative or quantitative defects of dysferlinLikely benign
(May 13, 2022)
criteria provided, single submitter
88.
GRCh37:
Chr2:71778826
GRCh38:
Chr2:71551696
DYSFQualitative or quantitative defects of dysferlinLikely benign
(Aug 21, 2022)
criteria provided, single submitter
89.
GRCh37:
Chr2:71762226
GRCh38:
Chr2:71535096
DYSFQualitative or quantitative defects of dysferlinLikely benign
(Jun 15, 2022)
criteria provided, single submitter
90.
GRCh37:
Chr2:71730334
GRCh38:
Chr2:71503204
DYSFQualitative or quantitative defects of dysferlinLikely benign
(Sep 23, 2022)
criteria provided, single submitter
91.
GRCh37:
Chr2:71886040
GRCh38:
Chr2:71658910
DYSFD1543E, D1564E, D1589E, D1544E, D1565E, D1575E, D1578E, D1595E, D1596E, D1557E, D1558E, D1574E, D1588E, D1579EQualitative or quantitative defects of dysferlinUncertain significance
(May 27, 2022)
criteria provided, single submitter
92.
GRCh37:
Chr2:71840475
GRCh38:
Chr2:71613345
DYSFQualitative or quantitative defects of dysferlinLikely benign
(Aug 13, 2022)
criteria provided, single submitter
93.
GRCh37:
Chr2:71871093
GRCh38:
Chr2:71643963
DYSFQualitative or quantitative defects of dysferlinLikely pathogenic
(Jul 10, 2022)
criteria provided, single submitter
94.
GRCh37:
Chr2:71730448
GRCh38:
Chr2:71503318
DYSFG115V, G114VQualitative or quantitative defects of dysferlinUncertain significance
(Mar 31, 2021)
criteria provided, single submitter
95.
GRCh37:
Chr2:71891389
GRCh38:
Chr2:71664259
DYSFQualitative or quantitative defects of dysferlinLikely benign
(Jun 8, 2022)
criteria provided, single submitter
96.
GRCh37:
Chr2:71788902
GRCh38:
Chr2:71561772
DYSFH714R, H729R, H760R, H715R, H745R, H728R, H746R, H759RQualitative or quantitative defects of dysferlinUncertain significance
(Aug 9, 2022)
criteria provided, single submitter
97.
GRCh37:
Chr2:71709090
GRCh38:
Chr2:71481960
DYSFG76R, G77RQualitative or quantitative defects of dysferlinUncertain significance
(Aug 21, 2022)
criteria provided, single submitter
98.
GRCh37:
Chr2:71762439
GRCh38:
Chr2:71535309
DYSFW467fs, W498fs, W466fs, W497fsQualitative or quantitative defects of dysferlinPathogenic
(Jan 14, 2022)
criteria provided, single submitter
99.
GRCh37:
Chr2:71883368
GRCh38:
Chr2:71656238
DYSFR1529Q, R1551Q, R1560Q, R1516Q, R1546Q, R1536Q, R1537Q, R1547Q, R1550Q, R1568Q, R1515Q, R1530Q, R1561Q, R1567QQualitative or quantitative defects of dysferlinLikely benign
(Aug 16, 2022)
criteria provided, single submitter
100.
GRCh37:
Chr2:71796946
GRCh38:
Chr2:71569816
DYSFQualitative or quantitative defects of dysferlinLikely benign
(Jun 2, 2022)
criteria provided, single submitter
Format
Items per page
Sort by
Choose Destination